HCA
COLL icon

Harbor Capital Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Harbor Capital Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$898K Buy
24,799
+1,311
+6% +$44.8K 0.06% 387
2026
Q1 		$777K Buy
23,488
+7,921
+51% +$335K 0.06% 375
2025
Q4 		$721K Buy
15,567
+418
+3% +$17.5K 0.06% 388
2025
Q3 		$530K Sell
15,149
-2,735
-15% -$95.1K 0.04% 464
2025
Q2 		$529K Sell
17,884
-2,957
-14% -$84.3K 0.02% 515
2025
Q1 		$622K Sell
20,841
-6,309
-23% -$193K 0.03% 506
2024
Q4 		$778K Buy
27,150
+3,652
+16% +$121K 0.03% 485
2024
Q3 		$908K Buy
23,498
+983
+4% +$35.1K 0.04% 473
2024
Q2 		$725K Buy
22,515
+8,842
+65% +$307K 0.06% 433
2024
Q1 		$531K Buy
+13,673
New +$478K 0.07% 383

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Harbor Capital Advisors's COLL Position: Q2 2026 in Review

Harbor Capital Advisors increased its Collegium Pharmaceutical (COLL) stake by 5.6% in Q2 2026, buying an estimated $44.8K and bringing the position to 24,799 shares worth $898K. The position accounts for 0.06% of the portfolio, ranked #387.

Harbor Capital Advisors first reported a position in COLL in Q1 2024 and has held it in 10 quarters since. The position peaked at $908K in Q3 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Harbor Capital Advisors held 24,799 shares of Collegium Pharmaceutical worth $898K as of Q2 2026.
  • Harbor Capital Advisors bought 1,311 Collegium Pharmaceutical shares in Q2 2026, an estimated $44.8K.
  • Collegium Pharmaceutical made up 0.06% of Harbor Capital Advisors's portfolio in Q2 2026, its #387 holding.
  • Harbor Capital Advisors first reported a position in Collegium Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
  • Harbor Capital Advisors's Collegium Pharmaceutical position peaked at $908K in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.